Fatchix - it's been fun, but I'm of the opinion you only read and hear what you want to hear. You seem to find arguments and disagreements in everything I say, even when I haven't even said many of those things. So I will try to keep it simple for those who would like to understand. If you would like find more arguments, feel free. I like to chuckle. But seriously, Lexipro. So here are the only two real things I am saying.
1. A product does not have to work or pass an FDA "test" of any kind other than being safe for human consumption in order to sell and make money. I listed several examples. I did not say they work. I said they sell. Thanks for confirming that point for me.
2. If a stock is trading, and the company is a product company, then a watershed event like getting the product on retail shelves does almost always have the effect of increasing the share price. I did not say Chas knows how to run a company. I did not comment on the reason for not trading. I do not care. I just want it trading.
Those were my only two real statements, and I really don't think there is much to debate about them. You did however, do us all one other favor. You confirmed you've shorted this stock, and thus we can use that information to judge what motives you might have and why you will not allow anyone to say anything remotely positive without launching into diatribes. We could be wrong, but IMO the odds are overwhelming that the motives have just been exposed. Again, thanks for the confirmation.
Finally, I did not say anything about my trading prowess. I have none. I know the drug industry and I have done well with a few of those stocks - simply based upon knowledge of what it takes to get drugs to market, what profit a mfg. or patent holder (often not the same entity) can make, and what's in their research pipeline . I never claimed to know anything about the drug store industry, nor did I make any statements that require such knowledge.
Again, two things:
1. A product's provable effectiveness does not always correlate to its a sales potential. Often times, useless products sell.
2. Product based companies, who put product on the shelves of major retail chains, tend to see increases in share price when stock of said company is trading normally.
Chas sucks. Something fishy is going on with accounting, shares are diluted, and all of that. But 1 and 2 above still hold true.
AI
